William David

2.6k total citations · 1 hit paper
18 papers, 962 citations indexed

About

William David is a scholar working on Neurology, Genetics and Pharmacology. According to data from OpenAlex, William David has authored 18 papers receiving a total of 962 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Neurology, 5 papers in Genetics and 4 papers in Pharmacology. Recurrent topics in William David's work include Amyotrophic Lateral Sclerosis Research (6 papers), Neurogenetic and Muscular Disorders Research (4 papers) and Cholinesterase and Neurodegenerative Diseases (2 papers). William David is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (6 papers), Neurogenetic and Muscular Disorders Research (4 papers) and Cholinesterase and Neurodegenerative Diseases (2 papers). William David collaborates with scholars based in United States, Switzerland and Sweden. William David's co-authors include Merit Cudkowicz, David Schoenfeld, Eric A. Macklin, Ericka Simpson, Stanley H. Appel, Matthew J. Crisp, Timothy M. Miller, Patricia L. Andres, C. Frank Bennett and Daniel A. Norris and has published in prestigious journals such as Neurology, The Lancet Neurology and Neuropharmacology.

In The Last Decade

William David

17 papers receiving 938 citations

Hit Papers

An antisense oligonucleotide against SOD1 delivered intra... 2013 2026 2017 2021 2013 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study
    2013 492 citations Timothy M. Miller, Alan Pestronk et al. The Lancet Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William David United States 11 507 436 367 197 89 18 962
Magdalena Kuźma‐Kozakiewicz Poland 17 661 1.3× 300 0.7× 396 1.1× 122 0.6× 118 1.3× 72 959
Akio Yokoseki Japan 17 750 1.5× 482 1.1× 380 1.0× 120 0.6× 139 1.6× 41 1.1k
Christoph Münch Germany 22 941 1.9× 438 1.0× 462 1.3× 407 2.1× 148 1.7× 46 1.5k
André Bento‐Abreu Belgium 12 372 0.7× 383 0.9× 231 0.6× 171 0.9× 118 1.3× 18 833
Françoise Darcel France 12 170 0.3× 382 0.9× 202 0.6× 201 1.0× 82 0.9× 29 1.1k
Pascale Hince Canada 11 277 0.5× 291 0.7× 162 0.4× 169 0.9× 48 0.5× 14 630
Philippe Guillet France 5 969 1.9× 262 0.6× 555 1.5× 218 1.1× 89 1.0× 9 1.2k
Hélène Tran France 10 616 1.2× 523 1.2× 332 0.9× 241 1.2× 134 1.5× 16 933
Megan A. O’Neill Canada 8 401 0.8× 530 1.2× 170 0.5× 65 0.3× 155 1.7× 10 883
Stephanie M. Patton United States 17 583 1.1× 292 0.7× 127 0.3× 33 0.2× 100 1.1× 24 1.3k

Countries citing papers authored by William David

Since Specialization
Citations

This map shows the geographic impact of William David's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William David with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William David more than expected).

Fields of papers citing papers by William David

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William David. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William David. The network helps show where William David may publish in the future.

Co-authorship network of co-authors of William David

This figure shows the co-authorship network connecting the top 25 collaborators of William David. A scholar is included among the top collaborators of William David based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William David. William David is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Dubey, Divyanshu, William David, Kerry L. Reynolds, et al.. (2019). Immune checkpoint inhibitor related neurologic adverse events: clinical spectrum, management and outcomes (S21.003). Neurology. 92(15_supplement). 2 indexed citations
2.
Sadjadi, Reza, Natalie Grant, Susan E. Thomas, et al.. (2019). Clinical myopathy in patients with nephropathic cystinosis. Muscle & Nerve. 61(1). 74–80. 15 indexed citations
3.
Fridman, Vera, Saranya Suriyanarayanan, Péter Novák, et al.. (2019). Randomized trial of l -serine in patients with hereditary sensory and autonomic neuropathy type 1. Neurology. 92(4). 76 indexed citations
4.
Benatar, Michael, Joanne Wuu, Peter M. Andersen, et al.. (2018). Randomized, double-blind, placebo-controlled trial of arimoclomol in rapidly progressive SOD1 ALS. Neurology. 90(7). e565–e574. 101 indexed citations
5.
Fullerton, Terence, Brendon Binneman, William David, et al.. (2018). A Phase 2 clinical trial of PF-05212377 (SAM-760) in subjects with mild to moderate Alzheimer’s disease with existing neuropsychiatric symptoms on a stable daily dose of donepezil. Alzheimer s Research & Therapy. 10(1). 38–38. 27 indexed citations
6.
7.
Delnomdedieu, Marielle, Anton Forsberg, Adam Ogden, et al.. (2017). In vivo measurement of PDE10A enzyme occupancy by positron emission tomography (PET) following single oral dose administration of PF-02545920 in healthy male subjects. Neuropharmacology. 117. 171–181. 22 indexed citations
8.
Martin, J.P., et al.. (2017). Life Springs. Scientific American. 27(3s). 28–28. 28 indexed citations
9.
Fullerton, Terence, Brendon Binneman, William David, et al.. (2016). P1‐047: A Phase 2 Clinical Trial of PF‐05212377 (SAM‐760) in Subjects with Mild to Moderate Alzheimer's Disease with Existing Neuropsychiatric Symptoms on a Stable Daily Dose of Donepezil. Alzheimer s & Dementia. 12(7S_Part_8). 1 indexed citations
10.
Narayanaswami, Pushpa, Richard Dubinsky, David Wang, et al.. (2015). Quality improvement in neurology. Neurology. 85(10). 905–909. 9 indexed citations
11.
Chad, David A. & William David. (2015). Neuromuscular Disorders. Seminars in Neurology. 35(4). 325–326. 3 indexed citations
12.
Gwathmey, Kelly, Mark R. Conaway, Reza Sadjadi, et al.. (2015). Construction and validation of the chronic acquired polyneuropathy patient‐reported index (CAP‐PRI): A disease‐specific, health‐related quality‐of‐life instrument. Muscle & Nerve. 54(1). 9–17. 17 indexed citations
13.
McElhiney, Martin, Judith G. Rabkin, Raymond R. Goetz, et al.. (2014). Seeking a measure of clinically meaningful change in ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 15(5-6). 398–405. 13 indexed citations
14.
Miller, Timothy M., Alan Pestronk, William David, et al.. (2013). An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study. The Lancet Neurology. 12(5). 435–442. 492 indexed citations breakdown →
15.
16.
Simmons, Zachary, Barbara A. Bremer, Susan Walsh, et al.. (2006). The ALSSQOL. Neurology. 67(9). 1659–1664. 96 indexed citations
17.
Lange, Dale J., Noah Lechtzin, Cynthia Davey, et al.. (2006). High-frequency chest wall oscillation in ALS. Neurology. 67(6). 991–997. 54 indexed citations
18.
David, William, et al.. (2002). Mechanical stimulation of intervertebral disc cells by cyclic hydrostatic pressure.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Magdalena Kuźma‐Kozakiewicz Breakdown of academic impact, for papers by Akio Yokoseki Breakdown of academic impact, for papers by Christoph Münch Breakdown of academic impact, for papers by André Bento‐Abreu Breakdown of academic impact, for papers by Françoise Darcel Breakdown of academic impact, for papers by Pascale Hince Breakdown of academic impact, for papers by Philippe Guillet Breakdown of academic impact, for papers by Hélène Tran Breakdown of academic impact, for papers by Megan A. O’Neill Breakdown of academic impact, for papers by Stephanie M. Patton
Rankless by CCL
2026